Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study

@article{Muehlbacher2005MirtazapineTO,
  title={Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study},
  author={M. Muehlbacher and M. Nickel and C. Nickel and C. Kettler and C. Lahmann and F. P. Gil and P. Leiberich and N. Rother and E. Bachler and R. Fartacek and P. Kaplan and K. Tritt and F. Mitterlehner and Javaid Anvar and W. Rother and T. Loew and C. Egger},
  journal={Journal of Clinical Psychopharmacology},
  year={2005},
  volume={25},
  pages={580-583}
}
  • M. Muehlbacher, M. Nickel, +14 authors C. Egger
  • Published 2005
  • Medicine, Psychology
  • Journal of Clinical Psychopharmacology
    • Abstract: Social phobia is an anxiety disorder characterized by extreme fear and phobic avoidance of social and performance situations and by a relatively poor health-related quality of life. The goal of this study was to compare the efficacy of mirtazapine versus placebo in the treatment of patients with social phobia. In 2004, we conducted a randomized, double-blind, placebo-controlled study of mirtazapine in 66 female subjects from the general population meeting the criteria for social… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    61 Citations
    Highly Influential Citations
    4
    Background Citations
    12
    Methods Citations
    2
    Results Citations
    5
    61 Citations
    Citation Type

    Citation Type

    Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study
    • 39
    • Highly Influenced
    Mirtazapine reduces social anxiety and improves quality of life in women with social phobia
    • E. Mörtberg
    • Psychology, Medicine
    • Evidence-based mental health
    • 2006
    • 4
    Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.
    • 36
    A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    • 52
    Pharmacotherapy for social anxiety disorder: a systematic review
    • 55
    Social Anxiety Disorder - A Review of Pharmacological Treatments
    • 11
    Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials
    • 20
    • Highly Influenced
    Optimal treatment of social phobia: systematic review and meta-analysis
    • 60
    • PDF
    Off-label use of mirtazapine for anxiety
    • PDF
    Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial

    References

    SHOWING 1-10 OF 34 REFERENCES
    Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    • 237
    Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
    • 96
    St. John's Wort Versus Placebo in Social Phobia: Results From a Placebo-Controlled Pilot Study
    • 45
    Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder: A Placebo-Controlled, Multicenter Study
    • 190
    Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    • 147
    A Double-Blind Placebo-Controlled Study of Controlled Release Fluvoxamine for the Treatment of Generalized Social Anxiety Disorder
    • 70
    Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration.
    • 48
    Mirtazapine in social anxiety disorder: a pilot study
    • 26
    Predictors of Response in Generalized Social Phobia: Effect of Age of Onset
    • 36
    Assessment and Treatment of Social Phobia
    • M. Antony
    • Psychology, Medicine
    • Canadian journal of psychiatry. Revue canadienne de psychiatrie
    • 1997
    • 33